𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children

✍ Scribed by Herson, Jay ;Starling, Kenneth A. ;Dyment, Paul G. ;Humphrey, G. Bennett ;Pullen, Jeanette ;Vats, Tribhawan

Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
332 KB
Volume
6
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Second remission induction rates for vincristine and prednisone alone (VP) and vincristine, L-asparaginase, and prednisone (VLP) are compared for children with acute lymphocytic leukemia. No evidence of a significant difference between the second induction complete remission rate for VP (78.6%) and VLP (73.7%) was found. Duration of first remission and prognostic group at initial diagnosis (defined on the basis of age and white blood count at initial diagnosis) are shown to be significant prognostic factors for second remission induction; and three second remission induction risk groups are defined on the basis of these two factors. Periodic reinforcement with prednisone in first remission does not appear to lower second induction complete response (CR) rates for VP. There was no evidence of a significant difference in the frequency of occurrence of severe toxicity between the VP and VLP regimens.

πŸ“œ SIMILAR VOLUMES

Cyclophosphamide-asparaginase-vincristin
Cyclophosphamide-asparaginase-vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia
✍ Diane M. Komp; Stephen L. George; John Falletta; Vita J. Land; Kenneth A. Starli πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 2 views

A remission-induction regimen for childhood leukemia using cyclophosphamide, asparaginase, vincristine, and prednisone (CAVP) was compared to standard vincristine-prednisone (VP) induction. The more intensive regimen was associated with a lower complete remission rate (81% vs 93%) and a higher early

L-asparaginase used with cytosine arabin
L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone
✍ Smithson, William A. ;Gilchrist, Gerald S. ;Burgert, E. Omer πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 458 KB

## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with L‐asparaginase and cytosine arabinoside (1‐β‐D‐arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1